Cancer Genomics - Proteomics: 9 (3)

May-June 2012; Volume 9,Issue 3

You have access
In Silico Functional Profiling of Individual Prostate Cancer Tumors: Many Genes, Few Functions
IVAN P. GORLOV, JINYOUNG BYUN and CHRISTOPHER J. LOGOTHETIS

Cancer Genomics & Proteomics May 2012, 9 (3) 109-114;
You have access
A Genetic Variant Located in miR-423 is Associated with Reduced Breast Cancer Risk
ROBERT A. SMITH, DOMINIK J. JEDLINSKI, PLAMENA N. GABROVSKA, STEPHEN R. WEINSTEIN, LARISA HAUPT and LYN R. GRIFFITHS

Cancer Genomics & Proteomics May 2012, 9 (3) 115-118;
You have access
Fully Human Targeted Cytotoxic Fusion Proteins: New Anticancer Agents on the Horizon
ULRICH H. WEIDLE, GUY GEORGES and ULRICH BRINKMANN

Cancer Genomics & Proteomics May 2012, 9 (3) 119-133;
You have access
The Spectra Count Label-free Quantitation in Cancer Proteomics
WEIDONG ZHOU, LANCE A. LIOTTA and EMANUEL F. PETRICOIN

Cancer Genomics & Proteomics May 2012, 9 (3) 135-142;
You have access
Microarray-based mRNA Expression Profiling of Leukemia Cells Treated with the Flavonoid, Casticin
CHIARA RIGHESCHI, TOLGA EICHHORN, ANASTASIA KARIOTI, ANNA RITA BILIA and THOMAS EFFERTH

Cancer Genomics & Proteomics May 2012, 9 (3) 143-151;
You have access
Modulation of Apoptosis Protein Profiles – Role of P-gp in HeLa Cells Exposed to Doxorubicin
BEATA M. GRUBER, JOLANTA KRZYSZTOŃ – RUSSJAN, IRENA BUBKO, MIROSŁAWA KORONKIEWICZ and ELŻBIETA L. ANUSZEWSKA

Cancer Genomics & Proteomics May 2012, 9 (3) 153-161;

Main menu